Copyright © 2002 by the European Society of Cardiology.
Editorials
Echocardiography or Nt-proANP in post-myocardial infarction patients: is one enough?
Lisbon University, Portugal
References
- N Engl J Med. 1983;309:331336[Abstract]
- St. John Sutton MG, Pfeffer MA, Plappert T. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 1994;89:6875
[Abstract/Free Full Text] - Patten RD, Udelson JE, Konstam MA. Left ventricular dysfunction and heart failure following myocardial infarction: early intervention in high risk patients. Sharpe N. Heart Failure Management. London: Martin Dunitz Ltd; 2000. p. 183198
- Hall C, Rouleau JL, Moyé LA. N-terminal proatrial natriuretic factor. An independent predictor of long term prognosis after myocardial infarction. Circulation. 1994;89:19341942
[Abstract/Free Full Text] - Otterstad JE, St. John Sutton MG, Froeland GS, Holme I, Skjaerje T, Hall C. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (27 days) and changes at 3 months in patients with a preserved systolic function. Eur Heart J. 2002;23:10111020
[Abstract/Free Full Text] - De Lemos JA, Morrow DA, Bentley JH. The prognostic value of B-type natriuretic peptide in patients with acute myocardial infarction. N Eng J Med. 2001;345:10141021
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||